Poor expression of T cell-derived cytokines and activation and proliferation markers in early rheumatoid synovial tissue

被引:46
作者
Smeets, TJM [1 ]
Dolhain, RJEM [1 ]
Miltenburg, AMM [1 ]
de Kuiper, R [1 ]
Breedveld, FC [1 ]
Tak, PP [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Rheumatol, NL-2300 RA Leiden, Netherlands
来源
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY | 1998年 / 88卷 / 01期
关键词
T cells; cytokines; early rheumatoid arthritis; immunohistochemistry;
D O I
10.1006/clin.1998.4525
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We compared the state of activation and proliferation of T cells in synovial tissue (ST) hom rheumatoid arthritis (RA) patients in early and late stages of the disease to find out whether T-cell-driven immune responses vary during the course of the disease. ST was obtained from 12 patients with early RA (< 1 year) and 12 patients with longstanding RA (> 5 years). T cells and interferon- (IFN-gamma)-positive cells were detected in ST using immunohistologic methods. To determine the percentage of T cells expressing the interleukin-a receptor, IFN-gamma, or the proliferation associated antigen Ki-67, immunofluorescence double-staining techniques were used. The scores for the number of T cells and for the expression of IFN-gamma as well as the percentages of T cells expressing CD25, IFN-gamma, or Ki-67 in rheumatoid synovium were not dependent on disease duration. These results do not support the assumption that the responsiveness of T cells in ST of RA patients differs between early and late stages of the disease. The data indicate that at present no arguments exist that the effect of T-cell-directed interventions on synovial inflammation might vary in different stages of the disease, (C) 1998 Academic Press.
引用
收藏
页码:84 / 90
页数:7
相关论文
共 50 条
[1]   ALTERED T-LYMPHOCYTE SIGNALING IN RHEUMATOID-ARTHRITIS [J].
ALLEN, ME ;
YOUNG, SP ;
MICHELL, RH ;
BACON, PA .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (06) :1547-1554
[2]   THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[3]  
Breedveld Ferdinand C., 1996, Current Opinion in Rheumatology, V8, P226, DOI 10.1097/00002281-199605000-00010
[4]  
BRENNAN F M, 1991, British Journal of Rheumatology, V30, P76
[5]  
BRENNAN FM, 1988, CLIN EXP IMMUNOL, V73, P417
[6]   CHARACTERIZATION OF T-CELL RECEPTOR-ALPHA-BETA REPERTOIRE IN SYNOVIAL TISSUE FROM DIFFERENT TEMPORAL PHASES OF RHEUMATOID-ARTHRITIS [J].
BUCHT, A ;
OKSENBERG, JR ;
LINDBLAD, S ;
GRONBERG, A ;
STEINMAN, L ;
KLARESKOG, L .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1992, 35 (02) :159-165
[7]  
CHU CQ, 1992, CLIN EXP IMMUNOL, V90, P522
[8]   CHRONIC EXPOSURE TO TUMOR-NECROSIS-FACTOR (TNF) IN-VITRO IMPAIRS THE ACTIVATION OF T-CELLS THROUGH THE T-CELL RECEPTOR CD3 COMPLEX - REVERSAL IN-VIVO BY ANTI-TNF ANTIBODIES IN PATIENTS WITH RHEUMATOID-ARTHRITIS [J].
COPE, AP ;
LONDEI, M ;
CHU, NR ;
COHEN, SBA ;
ELLIOTT, MJ ;
BRENNAN, FM ;
MAINI, RN ;
FELDMANN, M .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (02) :749-760
[9]   Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling [J].
Cope, AP ;
Liblau, RS ;
Yang, XD ;
Congia, M ;
Laudanna, C ;
Schreiber, RD ;
Probert, L ;
Kollias, G ;
McDevitt, HO .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (09) :1573-1584
[10]  
CUSH JJ, 1991, CLIN ORTHOP RELAT R, P9